Daniel J. Mangless is a Wisconsin-based activist investor, residing in De Pere, WI. While not operating a traditional fund (he doesn't file Form 13F), he's actively engaged in targeted governance campaigns through Schedule 13D and proxy solicitations .
II. Letters & Presentations
Letters
Zevra Therapeutics, Inc. - 3-Mar-2023
III. Significant companies
Below is a list of company engagements where the filer has filed a Schedule 13D and/or engaged in a proxy campaign. As the filer does not file a Form 13F, current ownership information is not available.
Zevra Therapeutics
Members Only · Snowball Research
Continue reading this report
Unlock the full analysis, investor activity breakdown, and complete commentary.
Try first
Free Trial
Submit a request with your professional email address and we'll send you a sample report.
Request Free Trial
Most popular
Subscribe
Full access to all reports, weekly digests, and the archive.
Subscribe Now
The best research idea generation service you've never heard of.
Edwin Dorsey · The Bear Cave · 2024 Hedge Fund Analyst Christmas List
Fresh, unbiased data which allows independent consumers to formulate their own opinion. Unique, stellar and a bargain.
J. Carlo Cannell · Cannell Capital LLC
Raghu's research saves us an enormous amount of time. Our payback on subscribing is enormous.
David Nierenberg · The D3 Family Funds